Legend Biotech Corp ADR (NASDAQ:LEGN)’s traded shares stood at 0.6 million during the last session, with the company’s beta value hitting 0.26. At the close of trading, the stock’s price was $35.64, to imply a decrease of -0.75% or -$0.27 in intraday trading. The LEGN share’s 52-week high remains $60.87, putting it -70.79% down since that peak but still an impressive 23.29% since price per share fell to its 52-week low of $27.34. The company has a valuation of $6.56B, with an average of 1.64 million shares in intraday trading volume over the past 10 days and average of 1.82 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Legend Biotech Corp ADR (LEGN), translating to a mean rating of 1.20. Of 11 analyst(s) looking at the stock, 0 analyst(s) give LEGN a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 11 recommend it as a Buy.
Legend Biotech Corp ADR (NASDAQ:LEGN) trade information
After registering a -0.75% downside in the last session, Legend Biotech Corp ADR (LEGN) has traded red over the past five days. The 5-day price performance for the stock is 6.45%, and 25.36% over 30 days. With these gigs, the year-to-date price performance is -22.56%. Short interest in Legend Biotech Corp ADR (NASDAQ:LEGN) saw shorts transact 14.37 million shares and set a 6.39 days time to cover.
The extremes give us $54 and $75 for target low and target high price respectively. As such, LEGN has been trading -110.44% off suggested target high and -51.52% from its likely low.
LEGN Dividends
Legend Biotech Corp ADR has its next earnings report out on 2025-May-13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Legend Biotech Corp ADR (NASDAQ:LEGN)’s Major holders
Legend Biotech Corp ADR insiders hold 1.33% of total outstanding shares, with institutional holders owning 47.77% of the shares at 48.42% float percentage. In total, 47.77% institutions holds shares in the company, led by FMR LLC. As of 2024-06-30, the company held over 17.62 million shares (or 9.6503% of shares), all amounting to roughly $780.46 million.
The next major institution holding the largest number of shares is PRICE T ROWE ASSOCIATES INC /MD/ with 11.49 million shares, or about 6.292% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $508.86 million.
We also have Fidelity Select Portfolios-Health Care Portfolio and AIM Investment Fd.s -Invesco Developing Markets Fd. as the top two Mutual Funds with the largest holdings of the Legend Biotech Corp ADR (LEGN) shares. Going by data provided on May 31, 2025 , Fidelity Select Portfolios-Health Care Portfolio holds roughly 3.45 shares. This is just over 1.88% of the total shares, with a market valuation of $123.02 million. Data from the same date shows that the other fund manager holds a little less at 2.69, or 1.46% of the shares, all valued at about 95.75 million.
